$0.81
-0.02 (-1.85%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,835.9% upside
Low Target
$22.24
Average Target
$31.94
High Target
$42.20
Current Price
$0.81
Current
$0.81
$0.81
Target
$31.94
$31.94
$22.24
$31.94 avg
$42.20
Scenario Analysis
Bear Case
$22.24
2,640.6%
Low target
Base Case
$31.94
+3,835.9%
Avg target
Bull Case
$42.20
+5,100.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.25
-63.9% from high
52-Week Low
$0.49
+65.3% from low
Target vs 52W High
$31.94
+1,319.6% vs high
Next Earnings Report
Aug 18, 2026
2d
until earnings
EPS Est: $-0.05
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |